Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Viridian Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 84
- +12 vs. Q1 2022
- Shares held
- 28.3M
- +3.39M (+13.6%) vs. Q1 2022
- Total value
- $327.7M
- −$133.2M (−28.9%) vs. Q1 2022
- New holders
- 32
- 21 more added
- Sold out
- 20
- 18 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 1,852,919 | $21.4M | 4.22% | 00.0% | Unchanged |
| BVF Inc | 1,744,012 | $20.2M | 0.97% | 00.0% | Unchanged |
| Commodore Capital LP | 1,638,609 | $19.0M | 4.01% | +687,270+72.2% | Added |
| BlackRock Inc. | 1,422,824 | $16.5M | 0.00% | +1,270,049+831.3% | Added |
| Vanguard Group Inc | 1,410,902 | $16.3M | 0.00% | +470,325+50.0% | Added |
| TCG Crossover Management, LLC | 1,314,000 | $15.2M | 6.46% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,306,569 | $15.1M | 3.01% | +50,518+4.0% | Added |
| Vivo Capital, LLC | 1,300,000 | $15.0M | 1.51% | 00.0% | Unchanged |
| Deep Track Capital, LP | 1,170,290 | $13.5M | 0.94% | 00.0% | Unchanged |
| Millennium Management LLC | 1,126,085 | $13.0M | 0.02% | +150,467+15.4% | Added |
| Frazier Life Sciences Management, L.P. | 980,302 | $11.3M | 1.07% | −759,228−43.6% | Reduced |
| Perceptive Advisors LLC | 971,832 | $11.2M | 0.35% | −451,221−31.7% | Reduced |
| Fairmount Funds Management LLC | 944,092 | $10.9M | 2.50% | 00.0% | Unchanged |
| Citadel Advisors LLC | 932,299 | $10.8M | 0.01% | −8,919−0.9% | Reduced |
| Cormorant Asset Management, LP | 877,500 | $10.2M | 0.79% | −122,500−12.3% | Reduced |
| Soleus Capital Management, L.P. | 841,018 | $9.73M | 1.56% | +751,018+834.5% | Added |
| Point72 Asset Management, L.P. | 790,400 | $9.14M | 0.04% | +490,400+163.5% | Added |
| D. E. Shaw & Co., Inc. | 759,128 | $8.78M | 0.01% | −23,967−3.1% | Reduced |
| Ghost Tree Capital, LLC | 600,000 | $6.94M | 4.77% | +133,597+28.6% | Added |
| Kynam Capital Management, LP | 590,143 | $6.83M | 1.76% | +317+0.1% | Added |
| Woodline Partners LP | 552,371 | $6.39M | 0.10% | +331,114+149.7% | Added |
| Ally Bridge Group (NY) LLC | 496,012 | $5.74M | 5.23% | 00.0% | Unchanged |
| State Street Corp | 455,065 | $5.26M | 0.00% | +389,065+589.5% | Added |
| Geode Capital Management, LLC | 449,660 | $5.20M | 0.00% | +250,422+125.7% | Added |
| Eversept Partners, LP | 445,592 | $5.16M | 0.50% | +289,849+186.1% | Added |
| Marshall Wace, LLP | 444,799 | $5.14M | 0.01% | +427,236+2,432.6% | Added |
| Tang Capital Management LLC | 400,000 | $4.63M | 0.70% | +400,000 | New |
| Franklin Resources Inc | 250,000 | $2.89M | 0.00% | −350,023−58.3% | Reduced |
| Northern Trust Corp | 243,956 | $2.82M | 0.00% | +187,469+331.9% | Added |
| Acuta Capital Partners, LLC | 234,026 | $2.71M | 1.51% | −105,974−31.2% | Reduced |
| Atlas Venture Advisors, Inc. | 209,505 | $2.42M | 0.77% | 00.0% | Unchanged |
| Walleye Capital LLC | 178,451 | $2.06M | 0.06% | +16,170+10.0% | Added |
| Pura Vida Investments, LLC | 105,460 | $1.22M | 0.19% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 90,072 | $1.04M | 0.17% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 87,254 | $1.01M | 0.00% | −10,273−10.5% | Reduced |
| LMR Partners LLP | 80,397 | $930.0K | 0.02% | +27,623+52.3% | Added |
| Bank of New York Mellon Corp | 69,280 | $802.0K | 0.00% | +69,280 | New |
| Charles Schwab Investment Management Inc | 68,246 | $790.0K | 0.00% | +68,246 | New |
| Bridger Management, LLC | 66,300 | $767.0K | 0.17% | +66,300 | New |
| Driehaus Capital Management LLC | 66,073 | $764.0K | 0.01% | +16,073+32.1% | Added |
| Polar Asset Management Partners Inc. | 59,700 | $691.0K | 0.01% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 58,915 | $681.0K | 0.00% | +58,915 | New |
| Alliancebernstein L.P. | 50,479 | $584.0K | 0.00% | +50,479 | New |
| Bellevue Group AG | 49,000 | $567.0K | 0.01% | +49,000 | New |
| HighVista Strategies LLC | 45,039 | $521.0K | 0.31% | −4,026−8.2% | Reduced |
| Swiss National Bank | 36,700 | $425.0K | 0.00% | +36,700 | New |
| UBS Oconnor LLC | 34,389 | $398.0K | 0.00% | +34,389 | New |
| Rhumbline Advisers | 31,713 | $367.0K | 0.00% | +31,713 | New |
| Morgan Stanley | 27,583 | $319.0K | 0.00% | −7,346−21.0% | Reduced |
| Jump Financial, LLC | 26,628 | $308.0K | 0.01% | +26,628 | New |
| Weiss Multi-Strategy Advisers LLC | 25,039 | $290.0K | 0.01% | +25,039 | New |
| California State Teachers Retirement System | 24,432 | $283.0K | 0.00% | +24,432 | New |
| Ensign Peak Advisors, Inc | 21,405 | $248.0K | 0.00% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 20,660 | $239.0K | 0.13% | −29,340−58.7% | Reduced |
| JPMorgan Chase & Co | 18,339 | $213.0K | 0.00% | −327−1.8% | Reduced |
| Barclays PLC | 18,295 | $212.0K | 0.00% | +1,295+7.6% | Added |
| New York State Common Retirement Fund | 17,800 | $206.0K | 0.00% | +17,800 | New |
| Credit Suisse AG | 17,780 | $206.0K | 0.00% | +17,780 | New |
| Caption Management, LLC | 17,777 | $206.0K | 0.02% | +17,777 | New |
| Alps Advisors Inc | 16,560 | $192.0K | 0.00% | +16,560 | New |
| MetLife Investment Management | 13,714 | $158.7K | 0.00% | +13,714 | New |
| Deutsche Bank AG | 12,768 | $148.0K | 0.00% | +12,768 | New |
| American International Group, Inc. | 12,078 | $140.0K | 0.00% | +12,078 | New |
| Bank of America Corp | 11,729 | $136.0K | 0.00% | −6,104−34.2% | Reduced |
| Dimensional Fund Advisors LP | 11,398 | $132.0K | 0.00% | +11,398 | New |
| Invesco Ltd. | 11,038 | $128.0K | 0.00% | +11,038 | New |
| State Board of Administration of Florida Retirement System | 11,040 | $128.0K | 0.00% | +11,040 | New |
| Manufacturers Life Insurance Company, The | 10,728 | $124.1K | 0.00% | +10,728 | New |
| Atom Investors LP | 10,699 | $124.0K | 0.05% | −5,407−33.6% | Reduced |
| PDT Partners, LLC | 10,114 | $117.0K | 0.01% | −4,276−29.7% | Reduced |
| Legal & General Group Plc | 8,104 | $94.0K | 0.00% | +8,104 | New |
| Amalgamated Bank | 3,860 | $45.0K | 0.00% | +3,860 | New |
| Tower Research Capital LLC (TRC) | 2,828 | $33.0K | 0.00% | +350+14.1% | Added |
| Citigroup Inc | 1,864 | $22.0K | 0.00% | −26,276−93.4% | Reduced |
| Ameritas Investment Partners, Inc. | 1,935 | $22.0K | 0.00% | +1,935 | New |
| Metropolitan Life Insurance Co | 1,592 | $18.4K | 0.00% | +1,592 | New |
| Simplex Trading, LLC | 1,239 | $14.0K | 0.00% | +1,239 | New |
| Lindbrook Capital, LLC | 1,006 | $12.0K | 0.00% | +1,006 | New |
| Wells Fargo & Company | 614 | $7.00K | 0.00% | +303+97.4% | Added |
| Royal Bank of Canada | 146 | $2.00K | 0.00% | −6,791−97.9% | Reduced |
| FMR LLC | 69 | $1.00K | 0.00% | +69 | New |
| UBS Group AG | 13 | $0 | 0.00% | −209−94.1% | Reduced |
| GPS Wealth Strategies Group, LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 40 | $0 | 0.00% | +40 | New |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,040,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −126,136−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −97,745−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −83,217−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −66,598−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −61,518−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −61,390−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −33,187−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −27,486−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,092−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −18,265−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −16,303−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Sciencast Management LP | 0 | $0 | 0.00% | −14,745−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |